The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Computer-Aided Drug Design
Abstract
Progress in genetic engineering has increased the need for, while advances in computational hardware have removed barriers impeding, the development of appropriate computational tools to assist in the understanding of molecular interactions. Advancements both in techniques and in broadening application have been clearly demonstrated. Further development requires progress in the fundamental aspects of theoretical chemistry as well as an increased base of experience in choosing the appropriate set of assumptions for a particular problem. Computer-aided drug design is a current reality, but one that, at its best, supplements an incomplete methodology with the traditional insight and wisdom of an experienced medicinal chemist. In the next few years progress in developing a sound theoretical foundation will make molecular design a realistic aid to the medicinal chemist and protein engineer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An all atom force field for simulations of proteins and nucleic acids
Weiner, S. J., Kollman, P. A., Nguyen, D. T., & Case, D. A. (1986) · Journal of Computational Chemistry · doi:10.1002/jcc.540070216 · Cited by 3,437
Goodford, P. J. (1985) · Journal of Medicinal Chemistry · doi:10.1021/jm00145a002 · Cited by 2,634
A geometric approach to macromolecule-ligand interactions
Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., & Ferrin, T. E. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90153-x · Cited by 2,278
Lumry, R., & Rajender, S. (1970) · Biopolymers · doi:10.1002/bip.1970.360091002 · Cited by 1,222
Design of Sequence-Specific DNA-Binding Molecules
Dervan, P. B. (1986) · Science · doi:10.1126/science.2421408 · Cited by 838
Fry, D. C., Kuby, S. A., & Mildvan, A. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.907 · Cited by 538
Hartmann, M. (1984) · Acta Polymerica · doi:10.1002/actp.1984.010350714 · Cited by 508
Binding of an antitumor drug to DNA
Kopka, M. L., Yoon, C., Goodsell, D. S., Pjura, P. E., & Dickerson, R. E. (1985) · Journal of Molecular Biology · doi:10.1016/0022-2836(85)90171-8 · Cited by 426
Electrostatic Effects in Proteins
Matthew, J. B. (1985) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.14.060185.002131 · Cited by 310
Guy, H. R. (1984) · Biophysical Journal · doi:10.1016/s0006-3495(84)84152-1 · Cited by 260
Cited by
Autodock Vina Adopts More Accurate Binding Poses but Autodock4 Forms Better Binding Affinity
Nguyen, N. T., Nguyen, T. H., Pham, T. N. H., Huy, N. T., Bay, M. V., Pham, M. Q., Nam, P. C., Vu, V. V., & Ngo, S. T. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00778 · Cited by 458
The future of molecular dynamics simulations in drug discovery
Borhani, D. W., & Shaw, D. E. (2012) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9517-y · Cited by 313
Structure-based drug design to augment hit discovery
Kalyaanamoorthy, S., & Chen, Y.-P. P. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.07.006 · Cited by 296
Molecular Similarity in Drug Design
(1995) · Springer eBooks · doi:10.1007/978-94-011-1350-2 · Cited by 291
Flexible ligand docking using a genetic algorithm
Oshiro, C. M., Kuntz, I. D., & Dixon, J. S. (1995) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124402 · Cited by 275
Metadata
- Authors
- Marshall, G. R.
- Venue
- Annual Review of Pharmacology and Toxicology
- Publisher
- Annual Reviews
- Published
- 1987-04
- Volume
- 27
- Issue
- 1
- Pages
- 193-213
- ISSN
- 0362-1642 (ISSN-L)
- 1545-4304
- OpenAlex
- W2170773610
- Cited by
- 255
- References
- 21
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Computer-Aided Drug Design. https://app.cochat.ai/papers/10.1146/annurev.pa.27.040187.001205
- The paper
- Marshall, G. R. (1987). Computer-Aided Drug Design. Annual Review of Pharmacology and Toxicology. https://doi.org/10.1146/annurev.pa.27.040187.001205
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.